(Q36091287)

12 August 2017

1 reference

title

Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation (English)

1 reference

12 August 2017

0 references

0 references

Varughese GI

1

1 reference

12 August 2017

Lip GY

series ordinal

2

1 reference

12 August 2017

language of work or name

1 reference

1 June 2005

1 reference

Journal of Human Hypertension

12 August 2017

published in

1 reference

12 August 2017

volume

19

1 reference

12 August 2017

issue

6

1 reference

12 August 2017

page(s)

421-424

1 reference

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Diabetes and hypertension physiopathology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

How well are hypertension and albuminuria treated in type II diabetic patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Antihypertensive therapy and endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

CD40 signaling and plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

7 January 2021

Long-term effects of ramipril and nitrendipine on albuminuria in hypertensive patients with type II diabetes and impaired renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

7 January 2021

Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: observations from Val-HeFT and CALM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

7 January 2021

Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

7 January 2021

Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001833

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001833

1 reference

12 August 2017

1 reference